Overview Nicotine Patch - Bioequivalence Study Status: Completed Trial end date: 2014-05-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the bioequivalence of a new transdermal nicotine patch to that of a reference formulation following repeated applications Phase: Phase 1 Details Lead Sponsor: Pierre Fabre MedicamentTreatments: Nicotine